Literature DB >> 20729907

Defining the role of APC in the mitotic spindle checkpoint in vivo: APC-deficient cells are resistant to Taxol.

S Radulescu1, R A Ridgway, P Appleton, K Kroboth, S Patel, J Woodgett, S Taylor, I S Nathke, O J Sansom.   

Abstract

Mutations in the adenomatous polyposis coli (APC) tumour suppressor are the key initiating event of colorectal cancer. Although the control of WNT signalling is well established as a central tumour-suppressive function, the significance of APC in regulating chromosome instability is less well established. In this study, we test whether APC-deficient cells have a functional spindle assembly checkpoint (SAC) in vivo by examining the response of these cells to Taxol and Vinorelbine. We also show for the first time that APC deficiency compromises the arrest response to Taxol in vivo. This effect is independent of the role that APC has in WNT signalling. At higher levels of Taxol, APC-deficient cells arrest as efficiently as wild-type cells. Importantly, this dose of Taxol strongly suppresses intestinal tumourigenesis in models of benign (APC(Min/+) mouse) and invasive (AhCreER(+)APC(fl/+)PTEN(fl/fl)) cancer. In contrast to intestinal enterocytes with a general SAC defect because of Bub1 (budding uninhibited by benzimidazole 1) deletion, APC-deficient enterocytes arrest equivalently to wild type when treated with Vinorelbine. This suggests that the failed arrest in response to Taxol is because of a specific defect in microtubule stabilization following Taxol treatment rather than a general role of the APC protein in the mitotic spindle checkpoint. In summary, this study clarifies the role of APC as a mitotic spindle checkpoint protein in vivo and shows that APC-deficient cells have a compromised response to Taxol.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20729907      PMCID: PMC3016607          DOI: 10.1038/onc.2010.373

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  32 in total

1.  Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene.

Authors:  H Shibata; K Toyama; H Shioya; M Ito; M Hirota; S Hasegawa; H Matsumoto; H Takano; T Akiyama; K Toyoshima; R Kanamaru; Y Kanegae; I Saito; Y Nakamura; K Shiba; T Noda
Journal:  Science       Date:  1997-10-03       Impact factor: 47.728

2.  Cancer cells display profound intra- and interline variation following prolonged exposure to antimitotic drugs.

Authors:  Karen E Gascoigne; Stephen S Taylor
Journal:  Cancer Cell       Date:  2008-07-24       Impact factor: 31.743

3.  Centrosome and spindle pole microtubules are main targets of a fluorescent taxoid inducing cell death.

Authors:  M Abal; A A Souto; F Amat-Guerri; A U Acuña; J M Andreu; I Barasoain
Journal:  Cell Motil Cytoskeleton       Date:  2001-05

Review 4.  Vinorelbine (Navelbine). A new semisynthetic vinca alkaloid.

Authors:  A Krikorian; F Breillout
Journal:  Onkologie       Date:  1991-02

5.  APC binds to the novel protein EB1.

Authors:  L K Su; M Burrell; D E Hill; J Gyuris; R Brent; R Wiltshire; J Trent; B Vogelstein; K W Kinzler
Journal:  Cancer Res       Date:  1995-07-15       Impact factor: 12.701

6.  Truncating APC mutations have dominant effects on proliferation, spindle checkpoint control, survival and chromosome stability.

Authors:  Anthony Tighe; Victoria L Johnson; Stephen S Taylor
Journal:  J Cell Sci       Date:  2004-11-23       Impact factor: 5.285

7.  APC and EB1 function together in mitosis to regulate spindle dynamics and chromosome alignment.

Authors:  Rebecca A Green; Roy Wollman; Kenneth B Kaplan
Journal:  Mol Biol Cell       Date:  2005-07-19       Impact factor: 4.138

8.  A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse.

Authors:  A R Moser; H C Pitot; W F Dove
Journal:  Science       Date:  1990-01-19       Impact factor: 47.728

9.  Inducible Cre-mediated control of gene expression in the murine gastrointestinal tract: effect of loss of beta-catenin.

Authors:  Heather Ireland; Richard Kemp; Carol Houghton; Louise Howard; Alan R Clarke; Owen J Sansom; Douglas J Winton
Journal:  Gastroenterology       Date:  2004-05       Impact factor: 22.682

Review 10.  MDR1/P-glycoprotein expression in colorectal cancer.

Authors:  S C Linn; G Giaccone
Journal:  Eur J Cancer       Date:  1995 Jul-Aug       Impact factor: 9.162

View more
  15 in total

1.  APC2 and Axin promote mitotic fidelity by facilitating centrosome separation and cytoskeletal regulation.

Authors:  John S Poulton; Frank W Mu; David M Roberts; Mark Peifer
Journal:  Development       Date:  2013-09-11       Impact factor: 6.868

2.  The APC tumor suppressor is required for epithelial cell polarization and three-dimensional morphogenesis.

Authors:  Alyssa C Lesko; Kathleen H Goss; Frank F Yang; Adam Schwertner; Imge Hulur; Kenan Onel; Jenifer R Prosperi
Journal:  Biochim Biophys Acta       Date:  2015-01-08

Review 3.  More than two decades of Apc modeling in rodents.

Authors:  Maged Zeineldin; Kristi L Neufeld
Journal:  Biochim Biophys Acta       Date:  2013-01-17

4.  The microtubule poison vinorelbine kills cells independently of mitotic arrest and targets cells lacking the APC tumour suppressor more effectively.

Authors:  Daniel M Klotz; Scott A Nelson; Karin Kroboth; Ian P Newton; Sorina Radulescu; Rachel A Ridgway; Owen J Sansom; Paul L Appleton; Inke S Näthke
Journal:  J Cell Sci       Date:  2012-03-07       Impact factor: 5.285

Review 5.  Wnt/beta-catenin signaling and small molecule inhibitors.

Authors:  Andrey Voronkov; Stefan Krauss
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

6.  MYC Is a Major Determinant of Mitotic Cell Fate.

Authors:  Caroline Topham; Anthony Tighe; Peter Ly; Ailsa Bennett; Olivia Sloss; Louisa Nelson; Rachel A Ridgway; David Huels; Samantha Littler; Claudia Schandl; Ying Sun; Beatrice Bechi; David J Procter; Owen J Sansom; Don W Cleveland; Stephen S Taylor
Journal:  Cancer Cell       Date:  2015-07-13       Impact factor: 31.743

7.  APC selectively mediates response to chemotherapeutic agents in breast cancer.

Authors:  Monica K VanKlompenberg; Claire O Bedalov; Katia Fernandez Soto; Jenifer R Prosperi
Journal:  BMC Cancer       Date:  2015-06-07       Impact factor: 4.430

8.  Cell-cycle synchronization reverses Taxol resistance of human ovarian cancer cell lines.

Authors:  Xueqing Wang; Lingya Pan; Ning Mao; Lifang Sun; Xiangjuan Qin; Jie Yin
Journal:  Cancer Cell Int       Date:  2013-07-30       Impact factor: 5.722

9.  E-cadherin can limit the transforming properties of activating β-catenin mutations.

Authors:  David J Huels; Rachel A Ridgway; Sorina Radulescu; Marc Leushacke; Andrew D Campbell; Sujata Biswas; Simon Leedham; Stefano Serra; Runjan Chetty; Guenievre Moreaux; Lee Parry; James Matthews; Fei Song; Ann Hedley; Gabriela Kalna; Fatih Ceteci; Karen R Reed; Valerie S Meniel; Aoife Maguire; Brendan Doyle; Ola Söderberg; Nick Barker; Alastair Watson; Lionel Larue; Alan R Clarke; Owen J Sansom
Journal:  EMBO J       Date:  2015-08-03       Impact factor: 11.598

Review 10.  MicroRNAs: key players of taxane resistance and their therapeutic potential in human cancers.

Authors:  Shi-Yun Cui; Rui Wang; Long-Bang Chen
Journal:  J Cell Mol Med       Date:  2013-09-23       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.